• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Surgery Partners Inc. (Amendment)

    12/21/23 4:48:54 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care
    Get the next $SGRY alert in real time by email
    SC 13D/A 1 d452818dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, DC 20549

     

     

    SCHEDULE 13D

    (Rule 13d-101)

    Information to be Included in Statements Filed Pursuant

    to § 240.13d-1(a) and Amendments Thereto Filed

    Pursuant to § 240.13d-2(a)

    Under the Securities Exchange Act of 1934

    (Amendment No. 8)

     

     

    Surgery Partners, Inc.

    (Name of Issuer)

    Common Stock, $0.01 par value per share

    (Title of Class of Securities)

    86881A 100

    (CUSIP Number)

    Bain Capital Investors, LLC

    200 Clarendon Street

    Boston, MA 02116

    617-516-2000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    December 19, 2023

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

     

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended (“Act”), or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 86881A100    13D    Page 2 of 8 Pages

     

      1.    

      Names of Reporting Persons

     

      BCPE Seminole Holdings LP

      2.  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(e) or 2(f)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

     

         7.    

      Sole Voting Power

     

      0

         8.  

      Shared Voting Power

     

      10,708,102 Shares

         9.  

      Sole Dispositive Power

     

      0

       10.  

      Shared Dispositive Power

     

      10,708,102 Shares

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      10,708,102 Shares

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      8.5%

    14.  

      Type of Reporting Person

     

      PN


    CUSIP No. 86881A100    13D    Page 3 of 8 Pages

     

      1.    

      Names of Reporting Persons

     

      BCPE Seminole Holdings II Intermediate, LP

      2.  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(e) or 2(f)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Delaware

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

     

         7.    

      Sole Voting Power

     

      0

         8.  

      Shared Voting Power

     

      30,055,197 Shares

         9.  

      Sole Dispositive Power

     

      0

       10.  

      Shared Dispositive Power

     

      30,055,197 Shares

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      30,055,197 Shares

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      23.8%

    14.  

      Type of Reporting Person

     

      PN


    CUSIP No. 86881A100    13D    Page 4 of 8 Pages

     

      1.    

      Names of Reporting Persons

     

      BCPE Seminole Holdings III, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(e) or 2(f)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

     

         7.    

      Sole Voting Power

     

      0

         8.  

      Shared Voting Power

     

      4,232,353 Shares

         9.  

      Sole Dispositive Power

     

      0

       10.  

      Shared Dispositive Power

     

      4,232,353 Shares

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      4,232,353 Shares

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      3.3%

    14.  

      Type of Reporting Person

     

      PN

     


    CUSIP No. 86881A100    13D    Page 5 of 8 Pages

     

      1.    

      Names of Reporting Persons

     

      BCPE Seminole Holdings IV, L.P.

      2.  

      Check the Appropriate Box if a Member of a Group

      (a)  ☐        (b)  ☐

     

      3.  

      SEC Use Only

     

      4.  

      Source of Funds

     

      AF

      5.  

      Check if Disclosure of Legal Proceedings is Required Pursuant to Item 2(e) or 2(f)

     

      ☐

      6.  

      Citizenship or Place of Organization

     

      Cayman Islands

    Number of

    Shares

     Beneficially 

    Owned by

    Each

    Reporting

    Person

    With:

     

         7.    

      Sole Voting Power

     

      0

         8.  

      Shared Voting Power

     

      4,951,320 Shares

         9.  

      Sole Dispositive Power

     

      0

       10.  

      Shared Dispositive Power

     

      4,951,320 Shares

    11.    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      4,951,320 Shares

    12.  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13.  

      Percent of Class Represented by Amount in Row (11)

     

      3.9%

    14.  

      Type of Reporting Person

     

      PN

     


    CUSIP No. 86881A100    13D    Page 6 of 8 Pages

     

    This Amendment No. 8 relates to the shares of common stock, $0.01 par value per share (the “Common Stock”), of Surgery Partners, Inc., a Delaware corporation (the “Issuer”), and amends the initial statement on Schedule 13D filed by BCPE Seminole Holdings LP on September 8, 2019, as amended by Amendment No. 1 filed on December 15, 2017, Amendment No. 2 filed on February 12, 2021, Amendment No. 3 filed on May 19, 2021, Amendment No. 4 filed on November 15, 2021, Amendment No. 5 filed on November 23, 2022 , Amendment No. 6 filed on December 27, 2022 and Amendment No. 7 filed on March 3, 2023 (the “Initial Statement” and, as further amended by this Amendment No. 8, the “Statement”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Initial Statement and unless amended and restated hereby, all information in the Initial Statement remains in effect, as supplemented hereby.

    Item 4. Purpose of Transaction.

    Item 4 of the Initial Statement is hereby amended and supplemented by adding the following at the end of Item 4 of the Initial Statement:

    December 2023 Secondary Offering

    On December 14, 2023, in connection with a registered secondary public offering (the “December 2023 Secondary Offering”) of Common Stock, BCPE Seminole and BCPE Seminole II, together with the other selling stockholders named therein, entered into an underwriting agreement (the “December 2023 Underwriting Agreement”) with the Issuer and Jefferies LLC (the “December 2023 Underwriter”). Pursuant to the December 2023 Underwriting Agreement, the selling stockholders agreed to sell to the December 2023 Underwriter, and the December 2023 Underwriter agreed to purchase from the selling stockholders, subject to and upon the terms and conditions set forth therein, an aggregate of 8,000,000 shares of Common Stock at a price of $33.44 per share. The December 2023 Secondary Offering closed on December 19, 2023.

    December 2023 Lock-up Agreement

    In connection with the December 2023 Secondary Offering, BCPE Seminole and BCPE Seminole II entered into a lock-up agreement (the “December 2023 Lock-Up Agreement”) with the December 2023 Underwriter. Under the December 2023 Lock-Up Agreement, BCPE Seminole and BCPE Seminole II agreed, subject to certain exceptions, not to offer, sell, pledge or otherwise transfer any shares of Common Stock for 45 days after December 14, 2023.

    The foregoing descriptions of the December 2023 Underwriting Agreement and the December 2023 Lock-up Agreement do not purport to be complete and are qualified in their entirety by reference to the full text of the December 2023 Underwriting Agreement, which includes the form of the December 2023 Lock-up Agreement as an exhibit, and which is incorporated by reference to Item 7.

    Item 5. Interest in Securities of the Issuer

    Item 5 of the Initial Statement is hereby amended and restated as follows:

    The information set forth in or incorporated by reference in Items 2, 3 and 4 and on the cover pages of this Statement is incorporated by reference in its entirety into this Item 5.


    CUSIP No. 86881A100    13D    Page 7 of 8 Pages

     

    (a)-(b)   

    As of the date hereof, BCPE Seminole holds 10,708,102 shares of Common Stock, representing approximately 8.5% of the issued and outstanding shares of Common Stock, BCPE Seminole II holds 30,055,197 shares of Common Stock, representing approximately 23.8% of the issued and outstanding shares of Common Stock, BCPE Seminole III holds 4,232,353 shares of Common Stock, representing approximately 3.3% of the outstanding shares of Common Stock, and BCPE Seminole IV holds 4,951,320 shares of Common Stock, representing approximately 3.9% of the outstanding shares of Common Stock.

     

    As a result of the foregoing and the relationships described in Item 2(a) of this Statement, the Reporting Persons may be deemed to beneficially own an aggregate of 49,946,972 shares of Common Stock, representing approximately 39.5% of the issued and outstanding shares of Common Stock.

       Ownership percentages set forth in this Statement are based upon a total of 126,488,626 shares of Common Stock issued and outstanding as of September 30, 2023, as reported by the Issuer in the prospectus supplement relating to the December 2023 Secondary Offering, filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act on December 14, 2023.
    (c)   

    On December 19, 2023, pursuant to the December 2023 Underwiring Agreement, BCPE Seminole and BCPE Seminole II sold 1,706,257 and 6,120,613 shares of Common Stock, respectively, at a price of $33.44 per share in the December 2023 Secondary Offering.

     

    Additionally, in connection with the consummation of the December 2023 Secondary Offering, on December 19, 2023, BCPE Seminole distributed 474,407 shares of Common Stock to certain partners and other employees of the Bain Capital Entities. The partners and other employees of the Bain Capital Entities that received shares of Common Stock from the distribution made charitable contributions of the shares of Common Stock.

    (d)    Except as stated within this Item 5, to the knowledge of the Reporting Persons, only the Reporting Persons have the right to receive, or the power to direct the receipt of, dividends from, or proceeds from the sale of, any of the shares of Common Stock beneficially owned by the Reporting Persons as described in this Item 5.
    (e)    Not applicable.

    Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

    Item 6 of the Initial Statement is hereby amended and supplemented by adding the following at the end of Item 6 of the Statement:

    The descriptions of the December 2023 Underwriting Agreement and the December 2023 Lock-Up Agreement in Item 4 above are hereby incorporated by reference into this Item 6.

    Item 7. Material to Be Filed As Exhibits.

    Item 7 of the Initial Statement is hereby amended and supplemented to add the following:

     

    Exhibit
    No .
      

    Description

    Exhibit
    11
       Underwriting Agreement, dated December 14, 2023 (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed by the Company with the SEC on December 18, 2023)


    CUSIP No. 86881A100    13D    Page 8 of 8 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

     

    Dated: December 21, 2023     BCPE Seminole Holdings LP
       

    By: BCPE Seminole GP LLC

           its general partner

       

    By: Bain Capital Investors, LLC

           its sole member

        By:  

    /s/ Andrew T. Kaplan

         

    Name: Andrew T. Kaplan

    Title: Partner

        BCPE Seminole Holdings II Intermediate, LP
       

    By: BCPE Seminole GP II LLC

           its general partner

       

    By: Bain Capital Investors, LLC

           its sole member

        By:  

    /s/ Andrew T. Kaplan

         

    Name: Andrew T. Kaplan

    Title: Partner

        BCPE Seminole Holdings III, L.P.
       

    By: BCPE Seminole GP III LLC

           its general partner

       

    By: Bain Capital Investors, LLC

           its sole member

        By:  

    /s/ Andrew T. Kaplan

         

    Name: Andrew T. Kaplan

    Title: Partner

        BCPE Seminole Holdings IV, L.P.
       

    By: BCPE Seminole GP LLC

           its general partner

       

    By: Bain Capital Investors, LLC

           its sole member

        By:  

    /s/ Andrew T. Kaplan

         

    Name: Andrew T. Kaplan

    Title: Partner

    Get the next $SGRY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGRY

    DatePrice TargetRatingAnalyst
    12/16/2024$30.00Buy
    BofA Securities
    10/14/2024$38.00Buy
    UBS
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    6/28/2024$31.00Outperform
    Macquarie
    3/6/2024$35.00Equal Weight
    Barclays
    11/14/2023$39.00 → $35.00Market Perform → Outperform
    TD Cowen
    6/2/2023$42.00 → $45.00Neutral → Buy
    BofA Securities
    5/12/2023$48.00Buy
    Mizuho
    More analyst ratings

    $SGRY
    Leadership Updates

    Live Leadership Updates

    See more
    • Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

      BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal

      1/13/25 5:00:24 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

      PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

      9/20/23 8:05:00 AM ET
      $SGRY
      $TDOC
      Hospital/Nursing Management
      Health Care
      Medical/Nursing Services
    • Akumin Provides Business Update and Announces CFO Transition

      PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr

      8/12/22 5:56:00 PM ET
      $AKU
      $ELV
      $SGRY
      Medical Specialities
      Health Care
      Hospital/Nursing Management

    $SGRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities initiated coverage on Surgery Partners with a new price target

      BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00

      12/16/24 6:50:04 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • UBS initiated coverage on Surgery Partners with a new price target

      UBS initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $38.00

      10/14/24 7:41:50 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • KeyBanc Capital Markets initiated coverage on Surgery Partners

      KeyBanc Capital Markets initiated coverage of Surgery Partners with a rating of Sector Weight

      10/11/24 7:53:18 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Exec Chairman of the Board Deveydt Wayne S was granted 4,233 shares, increasing direct ownership by 4% to 105,203 units (SEC Form 4)

      4 - Surgery Partners, Inc. (0001638833) (Issuer)

      3/25/25 4:32:57 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Chief Admin & Dev Officer Baldock Jennifer sold $14,651 worth of shares (612 units at $23.94), decreasing direct ownership by 0.26% to 236,047 units (SEC Form 4)

      4 - Surgery Partners, Inc. (0001638833) (Issuer)

      3/17/25 4:17:09 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Chief Human Resources Officer Burkhalter Danielle sold $1,760 worth of shares (74 units at $23.78), decreasing direct ownership by 0.16% to 44,839 units (SEC Form 4)

      4 - Surgery Partners, Inc. (0001638833) (Issuer)

      3/17/25 4:16:58 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance

      BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan

      5/12/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

      BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor

      4/18/25 2:09:12 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance

      BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net

      3/3/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Financials

    Live finance-specific insights

    See more

    $SGRY
    SEC Filings

    See more
    • Surgery Partners, Inc. Announces First Quarter 2025 Results; Reaffirms Full Year 2025 Guidance

      BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Highlights(All comparisons are year-over-year unless otherwise noted) Revenue increased 8.2% for the first quarter Same-facility revenues increased 5.2% for the first quarterSame-facility cases increased 6.5% for the first quarter Net loss attributable to Surgery Partners, Inc. was $37.7 million for the first quarter Adjusted EBITDA increased 6.6% to $103.9 million for the first quarter 2025 Guidan

      5/12/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call Details

      BRENTWOOD, Tenn., April 18, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2025 results before the market opens on Monday, May 12, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 26, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13752904 Interested investor

      4/18/25 2:09:12 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results; Sets 2025 Guidance

      BRENTWOOD, Tenn., March 03, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter and Full Year 2024 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 17.5% for the fourth quarter and 13.5% for the full year Same-facility revenues increased 5.6% for the fourth quarter and 8.0% for the full yearSame-facility cases increased 5.1% for the fourth quarter and 3.9% for the full year Net

      3/3/25 7:30:00 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

      SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

      5/14/25 12:24:27 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Surgery Partners Inc.

      10-Q - Surgery Partners, Inc. (0001638833) (Filer)

      5/12/25 4:25:46 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form SCHEDULE 13G filed by Surgery Partners Inc.

      SCHEDULE 13G - Surgery Partners, Inc. (0001638833) (Subject)

      5/12/25 10:44:45 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care

    $SGRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Surgery Partners Inc.

      SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

      11/8/24 10:46:38 AM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G filed by Surgery Partners Inc.

      SC 13G - Surgery Partners, Inc. (0001638833) (Subject)

      10/24/24 2:02:10 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)

      SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

      2/13/24 5:15:54 PM ET
      $SGRY
      Hospital/Nursing Management
      Health Care